Alimentary Tract and Metabolism Medicine sales in Australia stood at $1.02 billion US Dollars PPP in 2023. Sales are forecasted to reach $1.04 billion in 2024, marking a year-on-year increase of 1.96%. The upward trend is expected to continue with sales predicted to be $1.05 billion in 2025, $1.06 billion in 2026, and $1.07 billion in 2027, indicating annual growth rates of approximately 0.96%, 0.95%, and 0.94% respectively.
The Compound Annual Growth Rate (CAGR) for the five-year period from 2023 to 2027 is approximately 1.20%, highlighting a steady but moderate increase in sales.
Future trends to watch for include the impact of emerging therapies, healthcare policy changes, and demographic shifts, particularly aging population, which may drive higher demand for these medications.
